Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Balchem (BCPC) EPS (Weighted Average and Diluted) (2016 - 2026)

Balchem (BCPC) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $1.25 as the latest value for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) rose 10.62% year-over-year to $1.25; the TTM value through Mar 2026 reached $4.87, up 16.79%, while the annual FY2025 figure was $4.75, 20.87% up from the prior year.
  • EPS (Weighted Average and Diluted) hit $1.25 in Q1 2026 for Balchem, up from $1.21 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.25 in Q1 2026 and bottomed at $0.66 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.97, with a median of $0.93 recorded in 2023.
  • Year-over-year, EPS (Weighted Average and Diluted) surged 31.43% in 2022 and then dropped 21.35% in 2023.
  • Balchem's EPS (Weighted Average and Diluted) stood at $0.66 in 2022, then grew by 24.24% to $0.82 in 2023, then grew by 25.61% to $1.03 in 2024, then rose by 17.48% to $1.21 in 2025, then rose by 3.31% to $1.25 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $1.25, $1.21, and $1.24 for Q1 2026, Q4 2025, and Q3 2025 respectively.